Results 1 to 10 of about 1,869 (76)
Lenalidomideas a Second-line Therapy Achieves Long-term Remission in Elderly Patients with Relapsed/Refractory Multicentric Castleman's Disease：a Report of Two Cases and Literature Review [PDF]
, 2022 No standard therapy is recommended for elderly multicentric Castleman's disease (MCD) patients who failed to the first-line treatment or relapsed. Lenalidomide has been reported to be effective for relapsed/refractory MCD in foreign countries, but ...
TANG Yangming, SHI Renzhou, LAN Mei, LI Xuejun, WEN Zonghua, LU Xiaochen
core +1 more source
Clinical pathway for diagnosis and treatment of new diagnosed multiple myeloma in Guangxi [PDF]
Multiple myeloma, an incurable clonal plasma cell dysplasia, is the second most common hematological malignancy. Standardized diagnosis and treatment are crucial for prolonging the survival of myeloma patients and improving the quality of their lives ...
Guangxi Plasma Cell Disease Collaboration +1 more
core +1 more source
Multiple myeloma with cardiac amyloidosis and secondary adrenal cortical dysfunction: a case report [PDF]
Multiple myeloma is a malignant proliferative disease of plasma cells, and some patients may develop systemic amyloidosis. Cardiac amyloidosis is a common cause of death in these patients.
CHEN Haifei, ZHOU Lingyun
core +1 more source
Research progress of the immunosuppressive tumor microenvironment in multiple myeloma [PDF]
Multiple myeloma (MM) is a hematological malignancy originating from the immune system, and the immune microenvironment plays a pivotal role in its pathogenesis and progression.
Peng LIU, Yue WANG
core +1 more source
Zhongguo shiyan zhenduanxue, 2021 华氏巨球蛋白血症(Waldenstr9m’s macroglobulinemia,WM)是以淋巴浆细胞浸润骨髓同时伴血清单克隆性免疫球蛋白IgM增高为特点的惰性成熟B细胞淋巴瘤[1]。该病是一种少见的惰性成熟B细胞淋巴瘤,约占血液系统恶性肿瘤的1%-2%[2]。WM临床表现无特异性,容易漏诊、误诊。WM相关的肾损害在临床中比较少见。为此报道1例以轻链沉积病为首发表现的WM,以提高临床工作者对本病的认识。1临床资料患者,男,61岁。因"眼睑及四肢水肿伴乏力、气短8天 ...
杨婷, 胡晓, 沈卫章
doaj
血清免疫固定电泳、蛋白电泳、免疫球蛋白及轻链定量对多发性骨髓瘤临床诊断价值探讨
Zhongguo shiyan zhenduanxue, 2010 目的探讨血清蛋白电泳、总蛋白、免疫球蛋白及轻链、蛋白电泳、免疫固定电泳测定对多发性骨髓瘤（MM）的诊断价值。方法对89例多发性骨髓瘤患者的血清总蛋白、免疫球蛋白及轻链、蛋白电泳、免疫固定电泳和尿轻链κ、λ的检测结果进行统计分析。结果 89例MM患者38例患者血清总蛋白含量升高;55例免疫球蛋白及轻链定量显著升高;血清蛋白电泳56例检出M带,而免疫固定电泳中89例均为阳性结果。结论免疫固定电泳检是MM诊断的敏感方法 ,应作为MM的常规检测方法 。
刘汐盈, 孙淑艳, 宋媛媛
doaj
免疫固定电泳及免疫球蛋白定量在多发性骨髓瘤诊断和分型中的应用
Zhongguo shiyan zhenduanxue, 2016 目的探讨免疫固定电泳和免疫球蛋白定量在多发性骨髓瘤诊断和分型中的应用。方法采用血清蛋白电泳技术、免疫固定电泳技术、免疫比浊法对87例多发性骨髓瘤患者进行分析。结果 87例患者血清蛋白电泳77例检出M蛋白,阳性率为88.5%,免疫固定电泳均为阳性,免疫分型IgGκ29例,占33.3%;IgGλ22例,占25.3%;IgAκ10例,占11.5%;IgAλ12例,占13.8%;IgMκ4例,占4.6%;IgMλ3例,占3.4%;κ轻链2例,占2.3%;λ轻链5例,占5.7 ...
陈云峰, 葛亮, 沈建江
doaj
Zhongguo shiyan zhenduanxue, 2007 目的对62例多发性骨髓瘤（MM）患者免疫固定电泳（immunofixation electrophoresis,IFE）、血清蛋白电泳及免疫球蛋白定量结果进行分析,以探讨M蛋白、MM型别分布及其在MM中的临床诊断价值。方法血清蛋白和免疫固定电泳:采用全自动快速电泳分析系统进行电泳和扫描;免疫球蛋白定量:采用BECKMAN-COULTER IMAGE免疫化学分析仪,以速率散射比浊法分析,检测各样本的免疫球蛋白（IgGI、gMI、gA）含量。结果62例MM全部检出M带 ...
郑伟 +4 more
doaj
Zhongguo shiyan zhenduanxue, 2011 目的评价免疫固定电泳、尿液轻链定量及血清游离轻链检测在多发性骨髓瘤（MM）患者轻链检测中的价值。方法用速率散射比浊法进行重链、轻链及游离轻链定量,用蛋白电泳及免疫固定电泳法对M成份做定性分析,对多发性骨髓瘤患者轻链型21例,完整型29例（其中IgGI、gA型19例;IgD型10例）标本分别做免疫固定电泳,尿轻链定量及游离轻链检测,然后比较三种方法的检出率和灵敏度。结果对于轻链型骨髓瘤患者,免疫固定电泳、尿轻链定量及血清游离轻链检测三种方法的轻链检测阳性率分别为90.5%（19/21）;80.9%（17 ...
翟玉华 +3 more
doaj
Zhongguo shiyan zhenduanxue, 2020 多发性骨髓瘤(MM)是一种浆细胞克隆增殖性的恶性疾病,其特点是骨髓中浆细胞克隆性增殖,抑制正常多克隆B淋巴细胞生长,并分泌大量异常单克隆免疫球蛋白(M蛋白),导致异常球蛋白增加,正常球蛋白合成减少[1]。临床表现常常为高球蛋白血症以及由于大量免疫球蛋白(M蛋白)分泌所引起的一系列临床表现。目前,临床主要通过血清蛋白电泳或免疫固定电泳来评估分析M蛋白[2],从而帮助确诊MM。血清蛋白电泳具有结果准确 ...
余胜, 郑磊, 张鹏
doaj